AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. SymBio Pharmaceuticals Limited
  3. Financials
  4. FCF margin (%)

SymBio Pharmaceuticals Limited【JP:4582】

Market cap
¥7B
P/E ratio
-2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndFCF margin (%) YoY (%)
Dec 31, 2024-140.1+1862.91%
Dec 31, 2023-7.1-144.31%
Dec 31, 202216.1+1060.75%
Dec 31, 20211.4-101.00%
Dec 31, 2020-138.5-10.15%
Dec 31, 2019-154.2+150.95%
Dec 31, 2018-61.4-44.71%
Dec 31, 2017-111.1+32.65%
Dec 31, 2016-83.8-29.40%
Dec 31, 2015-118.7+77.01%
Dec 31, 2014-67

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)